I see, thanks for explaining it to me. Sometimes i’m a little slow.
RevImmune is also a coinventor on a patent (nwbo, ucla, revimmune, and the former nwbo CDMO that CRL acquired - having a senior moment trying to remember the name) and it may be the original combination treatment patent, but I could be mistaken.
I believe LP is directly associated with nwbo, advent, revimmune, and more! One of the companies LP is assovisted with added Dr Liau to their Scientific Advisory Panel I think, and I believe Bigger Capital has a large position in it.
I rely too much on memory and my retention and recall isn’t what it used to be. If I weren’t so lazy I would diagram all this stuff out and collect it in a file or database. But since I’m only invested in the nwbo part of LP’s world I figure I can get away with being lazy and I am strictly buy side for the duration with the exception of about 10% for personal family needs that I will need to sell, letting the rest ride and fulfill the greater potential.
The disclaimer: this is not investment advice
Market Data 
Markets 
AI
